Paul R. Helft

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma”.

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma

The Oncologist(2024)10.1093/oncolo/oyad331

N/A

1.4DataRank · unranked

46 citations

Menggang Yu, Barry Keane, David Mauro, Paul R. Helft, William Proctor Harris +6 more

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma

UNC Libraries(2024)10.17615/7zap-4733

N/A

0DataRank · unranked

0 citations

Barry Keane, David Mauro, Menggang Yu, Bert H. O’Neil, Paul R. Helft +6 more